By
AmyT on
December 2, 2011
Yesterday marks “a milestone” in the development of new technology to help automate the care and treatment of type 1 diabetes, according to JDRF!
The U.S. Food and Drug Administration unveiled its eagerly awaited Draft Guidance document for research and development of the Artificial Pancreas system, and initial reaction from JDRF — in a press conference held yesterday afternoon — was a mix of jubilation and a more measured response that they remain “guardedly optimistic” about the details…
Read more »
The Pancreum closed loop (automated insulin + CGM + glucagon) system that won a Grand Prize in the DiabetesMine Design Challenge this year may look like a pipe dream, but designer Gil DePaula assures us it is “visionary but real.”
Have a look at the video, below, and also Gil’s company website.
“The glucagon part is definitely a futuristic concept — because there’s no predicate device for glucagon delivery with the FDA, so that’s a…
Read more »
We recently mentioned a product called DiaPort from Roche, invented way back in 1998, which insulin researchers have been talking about lately as a possible alternative to the implantable insulin pump! Say what? you may ask. What makes this injection port with internal tubing so powerful? Especially when there’s a newer product called iPort that seems to do the same thing, possibly more elegantly?
Well, the DiaPort must be surgically implanted, and its advantage is…
Read more »
Over the weekend, I had the opportunity to attend the JDRF Capitol Chapter’s first annual Research Summit in Bethesda, MD. The summit had a very impressive line-up, including Dan Hurley, author of the book Diabetes Rising, and Dr. Aaron Kowalski, JDRF’s Vice President of Treatment Therapies.
I had the opportunity to speak with Dr. Edward Damiano, a researcher at Boston University who’s currently steeped in multi-day human trials for the control algorithm on the artificial…
Read more »
